🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 702712100
- Market Cap
- Mid Cap
- IPO
- 2/27/2020 · $18.00/share
Business: Passage Bio, Inc. is a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system diseases with limited or no approved treatment options. The company is based in Philadelphia, PA and has a strategic research collaboration agreement with the University of Pennsylvania and its Gene Therapy Program.
Company Contact
- CEO
- Willian Chou
- CFO
- Kathleen Borthwick
- Headquarters
-
, Philadelphia, PA 19103
- Phone
- 267-866-0311
- Investor Relations
- Sarah McCabe, Stern IR · 212-362-1200 · sarah.mccabe@sternir.com